ITCI Stock | Intra-Cellular Therapies Study 402 Topline Results Call
Intra-Cellular Therapies Announces Positive Topline Results from Study 402 Evaluating Lumateperone as Adjunctive Therapy in Patients with Bipolar Depression
Join the discussion below in the comment box.
Let us know in the comment below.
About the Earnings video
This is an Earnings report video which includes information about the latest EPS and revenue of the company.$ITCI
More videos
The mathematician who cracked Wall Street | Jim Simons
Tallest Buildings in Each U.S. State
The Billionaire Who Builds iPhones is Coming to America
Anton Kreil's BRUTAL Message! How Good Traders Manage Their Personal Lives
Anton Kreil - Celebrities are Disposable Commodities Serving the Media Agenda
Huawei's Founder Speaks To BBC
Anton Kreil ?" Rent to Own ?" Define Assets & Liabilities Properly
Anton Kreil Discusses Eliminating Emotion in Trading
What is Flipkart? | CNBC Explains
Walmart (WMT) Q4 2019 Earnings Call
Is China threatening Asia's financial center? | CNBC Explains
Tech Wash: are companies like Facebook, Google and Amazon too big?